Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1α expression in focal cerebral ischemia

Stroke

Volumn 39, Issue 3, 2008, Pages 1000-1006

  Sun, Li ^a   Marti, Hugo H ^a   Veltkamp, Roland ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral ischemia; EF 5; HBO; Hypoxia inducible factor 1 ; VEGF

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR; VASCULOTROPIN; 2-(2-NITRO-1H-IMIDAZOL-1-YL)-N-(2,2,3,3,3-PENTAFLUOROPROPYL)ACETAMIDE; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ETANIDAZOLE; FLUORINATED HYDROCARBON; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN MAPPING; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MARKER; DISEASE SEVERITY; FLUORESCENCE; HYPERBARIC OXYGEN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TOPOGRAPHY; ANIMAL; BRAIN; BRAIN CORTEX; C57BL MOUSE; CEREBRAL ARTERY DISEASE; DOWN REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; STAINING;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL CORTEX; CORPUS STRIATUM; DOWN-REGULATION; ETANIDAZOLE; FLUORESCENT ANTIBODY TECHNIQUE; HYDROCARBONS, FLUORINATED; HYPERBARIC OXYGENATION; HYPOXIA, BRAIN; HYPOXIA-INDUCIBLE FACTOR 1; INDICATORS AND REAGENTS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; OXYGEN; OXYGEN CONSUMPTION; RNA, MESSENGER; STAINING AND LABELING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41249087694     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.490599     Document Type: Article

References (42)

1. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-397.
2. Lo EH, Moskowitz MA, Jacobs TP. How brain cells die after stroke. Stroke. 2005;36:189-192.
3. Nighoghossian N, Trouillas P. Hyperbaric oxygen in the treatment of acute ischemic stroke: an unsettled issue. J Neurol Sci. 1997;150:27-31.
4. Helms AK, Whelan HT, Torbey MT. Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis. 2005;20:417-426.
5. Zhang JH, Lo T, Mychaskiw G, Colohan A. Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology. 2005;12:63-77.
6. Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford S, Rocksworld GL, Loewenson RB. A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke. 1991;22:1137-1142.
7. Nighoghossian N, Trouillas P, Adeleine P, Salord F. Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke. 1995;26:1369-1372.
8. Rusyniak DE, Kirk MA, May JD, Kao LW, Brizendine EJ, Welch JL, Cordell WH, Alonso RJ. Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke. 2003;34:571-574.
9. Zhang JH, Singhal AB, Toole JF. Oxygen therapy in ischemic stroke. Stroke. 2003;34:152-153.
10. Flynn EP, Auer RN. Eubaric hyperoxemia and experimental cerebral infarction. Ann Neurol. 2002;52:566-572.
11. Kim HY, Singhal AB, Lo EH. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol. 2005;57:571-575.
12. Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology. 2002;26:945-952.
13. Singhal AB, Wang X, Sumii T. Effect of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab. 2002;22:861-868.
14. Singhal AB, Benner T, Roccatagliata L. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36:797-802.
15. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999;30:2033-2037.
16. Liu S, Liu W, Ding W, Miyake M, Rosenberg GA, Liu K. Electron paramagnetic resonance-guided normobaric hyperoxia treatment protects the brain by maintaining penumbral oxygenation in a rat model of transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2006;26:1274-1284.
17. Demchenko IT, Luchakow YI, Moskvin AN, Gutsaeva DR, Allen BW, Talmann ED, Piantadosi CA. Cerebral blood flow and brain oxygenation in rats breathing oxygen under pressure. J Cereb Blood Flow Metab. 2005;25:1288-1300.
18. Watson NA, Beards SC, Altaf N, Kassner A, Jackson A. The effect of hyperoxia on cerebral blood flow: a study in healthy volunteers using magnetic resonance phase-contrast angiography. Eur J Anaesthesiol. 2000;17:152-159.
19. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
20. Veltkamp R, Sun L, Herrmann O, Wolferts G, Hagmann S, Siebing DA, Marti HH, Veltkamp C, Schwaninger M. Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res. 2006;1107:185-191.
21. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A. 1998;95:15809-15814.
22. Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, Koch CJ. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5. Br J Cancer. 1995;72:875-882.
23. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000;156:965-976.
24. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischemia in rat brain. Eur J Neurosci. 1999;11:4159-4170.
25. Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koos RD. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604-4613.
26. Henninger N, Fisher M. Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc Dis. 2006;21:134-136.
27. Veltkamp R, Warner DS, Domoki F, Brinkhous AD, Toole JF, Busija DW. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res. 2000;853:68-73.
28. Veltkamp R, Siebing DA, Heiland S. Hyperbaric oxygen induces rapid protection against focal cerebral ischemia. Brain Res. 2005;1037:134-138.
29. Veltkamp R, Siebing DA, Sun L. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke. 2005;36:1679-1683.
30. Lou M, Eschenfelder CC, Herdegen T, Brecht S. Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats. Stroke. 2004;35:578-583.
31. Schabitz WR, Schade H, Heiland S, Kollmar R, Bardutzky J, Henninger N, Muller H, Carl U, Toyokuni S, Sommer C, Schwab S. Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MR imaging. Stroke. 2004;35:1175-1179.
32. Koch CJ, Evens SM, Lord EM. Oxygen dependence of cellular uptake of EF5: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer. 1995;72:869-874.
33. Chavez JC, LaManna JC. Activation of hypoxia-induced factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci. 2002;22:8922-8931.
34. Mahy P, De Bast M, Gallez B, Gueulette J, Koch CJ, Scalliet P, Gregoire V. In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. Radiother Oncol. 2003;67:53-61.
35. Sharp FR, Bernaudin M. HIF-1 and oxygen sensing in the brain. Nat Rev Neurosci. 2004;5:437-448.
36. Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH. Multiple effects of hyperbaric oxygen on the expression of HIF-1α and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol. 2005;191:198-210.
37. Paschen W. Shutdown of translation: lethal or protective? Unfolded protein response versus apoptosis. J Cereb Blood Flow Metab. 2003;23:773-779.
38. Görlach A, Camenisch G, Kvietikova I, Vogt L, Wenger RH, Gassmann M. Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochim Biophys Acta. 2000;1493:125-134.
39. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell. 2002;13:1792-1801.
40. Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2005;25:554-571.
41. Kaya D, Gursoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T. VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab. 2005;25:1111-1118.
42. Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002;125:2549-2557.